Wolverine Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Wolverine Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20,700	Closed	-$121K	–	2313
2021 Q1	$121K	Sell	20,700 -1,000	-5%	-$6.92K	﹤0.01%	1391
2020 Q4	$74K	Sell	21,700 -700	-3%	-$1.33K	﹤0.01%	1273
2020 Q3	$32K	Buy	22,400 +5,200	+30%	+$9.26K	﹤0.01%	1338
2020 Q2	$34K	Sell	17,200 -16,000	-48%	-$31.4K	﹤0.01%	1310
2020 Q1	$64K	Sell	33,200 -6,200	-16%	-$18.5K	﹤0.01%	1134
2019 Q4	$163K	Sell	39,400 -207,300	-84%	-$798K	﹤0.01%	1003
2019 Q3	$742K	Sell	246,700 -11,600	-4%	-$35.9K	0.01%	677
2019 Q2	$1.62M	Buy	258,300 +8,600	+3%	+$51.5K	0.02%	493
2019 Q1	$1.39M	Buy	249,700 +218,800	+708%	+$1.33M	0.02%	542
2018 Q4	$205K	Buy	30,900 +20,300	+192%	+$164K	﹤0.01%	1236
2018 Q3	$113K	Buy	10,600 +6,200	+141%	+$71K	﹤0.01%	1268
2018 Q2	$52K	Buy	+4,400	New	+$45K	﹤0.01%	1238
2017 Q2	–	Sell	-2,200	Closed	-$31K	–	1382
2017 Q1	$31K	Buy	2,200 +100	+5%	+$1.48K	﹤0.01%	1059
2016 Q4	$29K	Buy	2,100 +1,600	+320%	+$25.7K	﹤0.01%	1058
2016 Q3	$9K	Buy	+500	New	+$8.05K	﹤0.01%	1168

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return